NCT04426422View on ClinicalTrials.gov

Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

September 30, 2018

Conditions
Type 2 Diabetes
Interventions
DRUG

Metformin Hydrochloride

treated with metformin 1500-2000mg daily

Trial Locations (1)

518000

Shenzhen People' S Hospital, Shenzhen

All Listed Sponsors
lead

Shenzhen People's Hospital

OTHER

NCT04426422 - Effect of Metformin on Gut Microbiota Changes and Glycemic Control of Newly Diagnosed Type 2 Diabetes | Biotech Hunter | Biotech Hunter